Fortress Biotech
FBIO
#9843
Rank
NZ$0.15 B
Marketcap
NZ$4.53
Share price
-3.61%
Change (1 day)
45.77%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): NZ$0.23 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are NZ$66.16 Million. In 2025 the company made an earning of -NZ$57.18 Million, an increase over its 2024 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.23 B-506.87%
2025 -NZ$57.18 Million-72.02%
2024 -NZ$0.21 Billion-21.6%
2023 -NZ$0.27 Billion-28.03%
2022 -NZ$0.37 Billion29.88%
2021 -NZ$0.28 Billion59.8%
2020 -NZ$0.18 Billion1.17%
2019 -NZ$0.18 Billion-19.84%
2018 -NZ$0.22 Billion28.99%
2017 -NZ$0.17 Billion37.92%
2016 -NZ$0.13 Billion32.31%
2015 -NZ$91.41 Million164.31%
2014 -NZ$34.59 Million-45.14%
2013 -NZ$63.04 Million37.55%
2012 -NZ$45.83 Million-22.91%
2011 -NZ$59.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
NZ$0.15 B-31.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-NZ$57.72 Million-125.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-NZ$57.49 Million-125.43%๐Ÿ‡บ๐Ÿ‡ธ USA